Clinical Trial Update: Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adalimumab (Humira) in children with polyarticular juvenile idiopathic arthritis has completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Arthritis, Juvenile Idiopathic | Phase 3 | Status: COMPLETED | Results posted: 2010-01-11